Overall NMR gets a fundamental rating of 3 out of 10. We evaluated NMR against 237 industry peers in the Capital Markets industry. NMR may be in some trouble as it scores bad on both profitability and health. NMR is not valued too expensively and it also shows a decent growth rate.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year NMR was profitable.
In the past year NMR had a positive cash flow from operations.
Each year in the past 5 years NMR has been profitable.
In multiple years NMR reported negative operating cash flow during the last 5 years.

1.2 Ratios

With a Return On Assets value of 0.61%, NMR is not doing good in the industry: 72.57% of the companies in the same industry are doing better.
The Return On Equity of NMR (10.62%) is better than 61.60% of its industry peers.
NMR's Return On Invested Capital of 0.68% is on the low side compared to the rest of the industry. NMR is outperformed by 69.20% of its industry peers.
NMR had an Average Return On Invested Capital over the past 3 years of 0.42%. This is significantly below the industry average of 7.27%.
The 3 year average ROIC (0.42%) for NMR is below the current ROIC(0.68%), indicating increased profibility in the last year.

		Industry Rank	Sector Rank
ROA	0.61%
ROE	10.62%
ROIC	0.68%

ROA(3y)0.36%

ROA(5y)0.36%

ROE(3y)5.9%

ROE(5y)5.66%

ROIC(3y)0.42%

ROIC(5y)0.41%

1.3 Margins

The Profit Margin of NMR (8.05%) is worse than 66.67% of its industry peers.
In the last couple of years the Profit Margin of NMR has declined.
The Operating Margin of NMR (11.60%) is worse than 64.98% of its industry peers.
NMR's Operating Margin has declined in the last couple of years.
NMR's Gross Margin of 43.38% is in line compared to the rest of the industry. NMR outperforms 45.57% of its industry peers.
In the last couple of years the Gross Margin of NMR has declined.

		Industry Rank	Sector Rank
OM	11.6%
PM (TTM)	8.05%
GM	43.38%

OM growth 3Y-11.17%

OM growth 5Y-4.76%

PM growth 3Y-7.1%

PM growth 5Y-8.33%

GM growth 3Y-22.42%

GM growth 5Y-9.54%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

Compared to 1 year ago, NMR has less shares outstanding
Compared to 5 years ago, NMR has less shares outstanding
NMR has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -0.22, we must say that NMR is in the distress zone and has some risk of bankruptcy.
NMR has a worse Altman-Z score (-0.22) than 80.59% of its industry peers.
A Debt/Equity ratio of 10.65 is on the high side and indicates that NMR has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 10.65, NMR is doing worse than 87.76% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	10.65
Debt/FCF	N/A
Altman-Z	-0.22

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

NMR has a Current Ratio of 0.27. This is a bad value and indicates that NMR is not financially healthy enough and could expect problems in meeting its short term obligations.
NMR's Current ratio of 0.27 is on the low side compared to the rest of the industry. NMR is outperformed by 82.28% of its industry peers.
A Quick Ratio of 0.27 indicates that NMR may have some problems paying its short term obligations.
NMR's Quick ratio of 0.27 is on the low side compared to the rest of the industry. NMR is outperformed by 82.28% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.27
Quick Ratio	0.27

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 34.52% over the past year.
The Earnings Per Share has been growing by 10.96% on average over the past years. This is quite good.
The Revenue has decreased by -2.45% in the past year.
The Revenue has been growing by 19.39% on average over the past years. This is quite good.

EPS 1Y (TTM)34.52%

EPS 3Y34.65%

EPS 5Y10.96%

EPS Q2Q%-6.73%

Revenue 1Y (TTM)-2.45%

Revenue growth 3Y43.77%

Revenue growth 5Y19.39%

Sales Q2Q%-8.91%

3.2 Future

NMR is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.79% yearly.
Based on estimates for the next years, NMR will show a decrease in Revenue. The Revenue will decrease by -5.88% on average per year.

EPS Next Y10.55%

EPS Next 2Y3.07%

EPS Next 3Y3.79%

EPS Next 5YN/A

Revenue Next Year-18.17%

Revenue Next 2Y-9.64%

Revenue Next 3Y-5.88%

Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

NMR is valuated reasonably with a Price/Earnings ratio of 10.83.
Based on the Price/Earnings ratio, NMR is valued a bit cheaper than 64.56% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.60. NMR is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 11.20, which indicates a very decent valuation of NMR.
66.67% of the companies in the same industry are more expensive than NMR, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 25.83. NMR is valued rather cheaply when compared to this.

		Industry Rank	Sector Rank
PE	10.83
Fwd PE	11.2

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NMR indicates a somewhat cheap valuation: NMR is cheaper than 70.04% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	21.26

4.3 Compensation for Growth

NMR's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.

PEG (NY)1.03

PEG (5Y)0.99

EPS Next 2Y3.07%

EPS Next 3Y3.79%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.61%, NMR has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 5.87, NMR has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 1.82, NMR pays a better dividend.

		Industry Rank	Sector Rank
Dividend Yield	3.61%

5.2 History

The dividend of NMR is nicely growing with an annual growth rate of 15.59%!
NMR has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of NMR decreased in the last 3 years.

Dividend Growth(5Y)15.59%

Div Incr Years2

Div Non Decr Years2

5.3 Sustainability

NMR pays out 45.53% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of NMR is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.

DP45.53%

EPS Next 2Y3.07%

EPS Next 3Y3.79%

More info and screens

Find the best dividend stocks

Show peers with best dividend

NOMURA HOLDINGS INC-SPON ADR / NMR FAQ

Can you provide the ChartMill fundamental rating for NOMURA HOLDINGS INC-SPON ADR?

ChartMill assigns a fundamental rating of 3 / 10 to NMR.

What is the valuation status of NOMURA HOLDINGS INC-SPON ADR (NMR) stock?

ChartMill assigns a valuation rating of 5 / 10 to NOMURA HOLDINGS INC-SPON ADR (NMR). This can be considered as Fairly Valued.

Can you provide the profitability details for NOMURA HOLDINGS INC-SPON ADR?

NOMURA HOLDINGS INC-SPON ADR (NMR) has a profitability rating of 3 / 10.

What is the financial health of NOMURA HOLDINGS INC-SPON ADR (NMR) stock?

The financial health rating of NOMURA HOLDINGS INC-SPON ADR (NMR) is 1 / 10.

What is the earnings growth outlook for NOMURA HOLDINGS INC-SPON ADR?

The Earnings per Share (EPS) of NOMURA HOLDINGS INC-SPON ADR (NMR) is expected to grow by 10.55% in the next year.